Eupraxia Pharmaceuticals EPRX
NASDAQ EPRX
$8.31 +0.10 (+1.16%)
At close: Sep 29, 2026 · 4:00 PM EDT

Eupraxia Pharmaceuticals (EPRX) Assets (2022 - 2026)

Updated

Eupraxia Pharmaceuticals (EPRX) recorded Assets of $139.91 million in the quarter ended Jun 30, 2026, up 492.9% from $23.6 million a year earlier but down 3.7% from the prior quarter.

Analysis

Eupraxia Pharmaceuticals (EPRX) Assets (2022 - 2026) Analysis & Trends

As of Dec 31, 2025, Eupraxia Pharmaceuticals reported Assets of $86.15 million, up 146.5% from the prior year.

  • Annual Assets has increased for three straight years, with a three-year compound annual growth rate of 65.2% (years ended Dec 2022 to Dec 2025).
  • Across earlier years, Assets came in at $34.94 million in the year ended Dec 31, 2024 (+72.4%), $20.27 million in the year ended Dec 31, 2023 (+6.0%) and $19.12 million in the year ended Dec 31, 2022.
  • Quarterly Assets has ranged from $10.36 million in the quarter ended Sep 30, 2024 to $145.35 million in the quarter ended Mar 31, 2026 over the past five years.
  • On a year-over-year basis, Assets has increased for four consecutive quarters, with growth averaging 267.8% over the last seven quarters.
  • Peak year-over-year performance for Assets in the last five years was growth of 791.0% in the quarter ended Sep 30, 2025, against a decline of 20.2% in the quarter ended Mar 31, 2025 at the low end.
  • Per Business Quant, the preceding three quarters came in at $145.35 million (quarter ended Mar 31, 2026), $86.15 million (quarter ended Dec 31, 2025) and $92.35 million (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 201.06 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 135.12 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 129.80 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 122.03 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 115.83 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 95.64 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 49.36 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 201.13 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 27.42 Bn
10 Eupraxia Pharmaceuticals 328.04 Mn 326.44 Mn - 139.91 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 139.91 Mn
Mar 31, 2026 145.35 Mn
Dec 31, 2025 86.15 Mn
Sep 30, 2025 92.35 Mn
Jun 30, 2025 23.60 Mn
Mar 31, 2025 29.23 Mn
Dec 31, 2024 34.94 Mn
Sep 30, 2024 10.36 Mn
Jun 30, 2024 24.98 Mn
Mar 31, 2024 36.64 Mn
Dec 31, 2023 20.27 Mn
Dec 31, 2022 19.12 Mn
API Access

Eupraxia Pharmaceuticals Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=assets&ticker=EPRX&period=max&api_key=YOUR_API_KEY